EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Hydrophobic Ion-Paired Self-Microemulsifying System Enhances Jejunal Absorption and Acute Glycemic Control of Semaglutide in Rats

Ke Wang, Yijie Hu, Yicheng Jiang iD, Ruixin Fan, Yuzhang Bao, Sikai Wang, Qian Liang, Kaili Lu, Junjie Xue, Yi Yan, Xiaoyan Liu, Wanhui Liu und 2 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27219523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ke Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Innovative Formulations and Pharmaceutical Excipients, Peking University Ningbo Institute of Marine Medicine, Ningbo 315832, China. Hauptthemen laut MEDLINE: Glucagon-Like Peptides, Jejunum, Intestinal Absorption, Hypoglycemic Agents. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ningbo Science and Technology Bureau, National Natural Science Foundation of China, Ningbo Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral delivery of semaglutide offers a promising strategy for type 2 diabetes mellitus (T2DM) by improving patient adherence. However, its clinical translation is limited by low oral bioavailability, resulting from the peptide’s hydrophilicity, instability in gastrointestinal environments, and poor intestinal permeability. To address these challenges, semaglutide was converted into a hydrophobic ion-pair (HIP) complex with the cationic lipid DODAB (termed SEDAB), which was subsequently incorporated into a self-microemulsifying drug delivery system (SMEDDS), yielding SEDAB-SME. A comparative screen of two cationic amphiphiles identified DODAB as the selected counterion, which forms a stable complex with semaglutide. Ion pairing with DODAB markedly increased the lipophilicity of semaglutide, and the resulting SEDAB-SME formulation enhanced its stability in simulated intestinal fluid, effectively protecting the peptide from enzymatic degradation. In vitro, FITC-semaglutide delivered by SEDAB-SME showed markedly greater cell association than native FITC-semaglutide, and inhibitor studies suggested the involvement of a cholesterol-sensitive, raft-associated internalization route. In an intra-jejunal (i.j.) regional intestinal absorption study in SD rats, SEDAB-SME enhanced jejunal absorption of semaglutide (Frel = 0.12%) by approximately 28-fold compared with native semaglutide administered via the same i.j. route. In an acute single-dose pharmacodynamic study in STZ-induced T2DM rats, oral administration of SEDAB-SME enteric-coated capsules significantly reduced blood glucose levels. These results demonstrate that the HIP-SMEDDS strategy markedly enhanced regional jejunal absorption and produced acute glucose-lowering effects in a rodent model. This proof-of-concept study highlights a promising approach that warrants further validation of direct oral pharmacokinetics and long-term safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like PeptidesJejunumIntestinal AbsorptionHypoglycemic AgentsBlood GlucoseAnimalsSemaglutideHydrophobic and Hydrophilic InteractionsRatsMaleEmulsionsRats, Sprague-DawleyDrug Delivery SystemsDiabetes Mellitus, Type 2HumansAdministration, OralDiabetes Mellitus, ExperimentalBiological Availability

Stichwörter der Autor:innen

hydrophobic ion pairjejunal absorptionoral deliveryself-microemulsifying drug delivery systemssemaglutidetype 2 diabetes mellitus

Substanzen

SemaglutideGlucagon-Like PeptidesEmulsionsHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Laboratory of Innovative Formulations and Pharmaceutical Excipients, Peking University Ningbo Institute of Marine Medicine, Ningbo 315832, China.
  • Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

ORCID-Profile: Yicheng Jiang

Förderung

  • Ningbo Science and Technology Bureau
  • National Natural Science Foundation of China
  • Ningbo Science and Technology Plan Project

Zitieren

APA

Wang, K., Hu, Y., Jiang, Y., Fan, R., Bao, Y., Wang, S., Liang, Q., Lu, K., Xue, J., Yan, Y., Liu, X., Liu, W., Zhu, Y., & Wang, J. (2026). A Hydrophobic Ion-Paired Self-Microemulsifying System Enhances Jejunal Absorption and Acute Glycemic Control of Semaglutide in Rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219523

Vancouver

Wang K, Hu Y, Jiang Y, Fan R, Bao Y, Wang S, et al. A Hydrophobic Ion-Paired Self-Microemulsifying System Enhances Jejunal Absorption and Acute Glycemic Control of Semaglutide in Rats. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219523

BibTeX
@article{Wang2026,
  author = {Wang, Ke and Hu, Yijie and Jiang, Yicheng and Fan, Ruixin and Bao, Yuzhang and Wang, Sikai and Liang, Qian and Lu, Kaili and Xue, Junjie and Yan, Yi and Liu, Xiaoyan and Liu, Wanhui and Zhu, Yuanjun and Wang, Jiancheng},
  title = {A Hydrophobic Ion-Paired Self-Microemulsifying System Enhances Jejunal Absorption and Acute Glycemic Control of Semaglutide in Rats},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27219523}
}
Kostenlos starten →